Skip to main content
OpenTrials
Completed

NCT Number: NCT02036632

Eye Patch Therapy for Central Serous Retinopathy (CSR)

First, this study will investigate the viability of 24-hour eye patching as a potential treatment modality for CSR. Second, this study will assess a potential physiologic explanation for CSR, namely if inhibition of photic stimulation of the diseased retina will aid in ameliorating disease severity and disease duration.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Central Serous Retinopathy (CSR) Central Serous Chorioretinopathy Eye Diseases Retinal Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

Washington Universtiy School of Medicine

St Louis, Missouri, 63110, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults 18 years of age and older
  • Both males and females
  • Patients diagnosed with active central serous retinopathy
  • Patients who are willing to use an eye patch in the affected eye for 24 hours
  • Patients who are able to make the follow up appointments as required by the study

Exclusion criteria

  • Individuals under 18 years of age
  • Patients with vision less than 20/40 in the unaffected eye.
  • Patients who are not able to undergo mfERG testing in a realiable manner.

Treatment and study plan

Eye Patching

Device

Primary outcomes

  1. Change in multi-focal ERG response and macular thickness after 24-hour patch therapy in patients with CSR

    Time frame: 24 hours

    This study is a prospective control trial that will compare 24-hour eye patch therapy with the current standard of care in patients with central serous retinopathy (CSR).

  2. Change in multi-focal ERG response

    Time frame: 24 hours

Secondary outcomes

  1. macular thickness

    Time frame: 24 hours

Sponsors and collaborators

Lead sponsor

Washington University School of Medicine

Other

Registry information

Official study title

Eye Patching as a Potential Treatment Modality for and a Possible Etiological Insight on Central Serous Retinopathy

Important dates

Study start
2012
Primary completion
2015
Study completion
2015
First posted
Jan 15, 2014
Registry last updated
Jun 3, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.